삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

병리과 조은윤 교수

진료분야
유방암병리, 유방종양병리
진료일정 04 月
날짜
월
01
화
02
수
03
목
04
금
05
토
06
일
07
월
08
화
09
수
10
목
11
금
12
토
13
일
14
월
15
화
16
수
17
목
18
금
19
토
20
일
21
월
22
화
23
수
24
목
25
금
26
토
27
일
28
월
29
화
30
오전
오후
진료일정 05 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
금
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2004.08 성균관대학교 대학원 의학과 박사
1999.02 서울대학교 대학원 의학과 석사
1996.02 서울대학교 의과대학 의학사

경력

경력
2019.0401 ~현재 성균관대학교 의과대학 병리학교실 교수
2013.04 ~ 2019.03 성균관대학교 의과대학 병리학교실 부교수
2009.03 ~ 2013.03 성균관대학교 의과대학 병리학교실 조교수
2005.03 ~ 2009.02 삼성서울병원 병리과 임상조교수
2001.12 ~ 2005.02 강북삼성병원 병리과 전임의 및 전문의
2001.03 ~ 2001.11 서울아산병원 병리과 전임의
1997.03 ~ 2001.02 삼성서울병원 병리과 레지던트
1996.03 ~ 1997.02 서울대학교병원 인턴

학회활동

학회활동
2008.06 ~ 현재 한국유방암학회 평생회원
2008.03 ~ 현재 대한세포병리학회 정회원
2007.03 ~ 현재 유방병리동호회 회원
2001.02 ~ 현재 대한병리학회 평생회원
논문
  • HUM PATHOL 2024 10.1016/j.humpath.2024.02.002 Residual pure intralymphatic carcinoma component only (lymphovascular tumor emboli without invasive carcinoma) after neoadjuvant chemotherapy is associated with poor outcome: Not pathologic complete response Lee, H; Jang, Y; Cho, YA; Cho, EY
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.800 Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine Lee, H; Cho, YA; Kim, DG; Cho, EY
    View PubMed
  • INT J MOL SCI 2023 10.3390/ijms242115576 A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Jung, HH; Kim, JY; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • EXP MOL MED 2023 10.1038/s12276-023-01030-z Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer Kim, JY; Park, S; Cho, EY; Lee, JE; Jung, HH; Chae, BJ; Kim, SW; Nam, SJ; Cho, SY; Park, YH; Ahn, JS; Lee, S; Im, YH
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1146934 Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer Kim, JY; Kim, J; Cho, EY; Park, YH; Ahn, JS; Kim, KM; Im, YH
    View PubMed
  • VIRCHOWS ARCH 2022 10.1007/s00428-022-03280-0 Histologic analysis according to HER2 gene status in HER2 2+invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations Hwang, HW; Hong, SA; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY
    View PubMed
  • NPJ BREAST CANCER 2022 10.1038/s41523-021-00364-z Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer Park, KW; Kim, SW; Han, H; Park, M; Han, BK; Ko, EY; Choi, JS; Cho, EY; Cho, SY; Ko, ES
    View PubMed
  • CANCERS 2021 10.3390/cancers13215260 Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy Jung, HH; Kim, JY; Cho, EY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-96855-x Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients Cho, SY; Lee, JH; Ryu, JM; Lee, JE; Cho, EY; Ahn, CH; Paeng, K; Yoo, I; Ock, CY; Song, SY
    View PubMed
  • BREAST CANCER RES TR 2021 10.1007/s10549-021-06310-8 Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer Kim, JY; Jeon, E; Kwon, S; Jung, H; Joo, S; Park, Y; Lee, SK; Lee, JE; Nam, SJ; Cho, EY; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • CANCERS 2021 10.3390/cancers13040739 Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells Kim1, D; Kim, Y; Lee, BB; Cho, EY; Han, J; Shim, YM; Kim, DH
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9103067 Negative Effect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer Kim1, D; Kim, Y; Lee, BB; Kim, D; Lee, OJ; Jeong, P; Kim, WJ; Cho, EY; Han, J; Shim, YM; Kim, DH
    View PubMed
  • ASIA-PAC J CLIN ONCO 2020 10.1111/ajco.13444 Distribution of tumor subtypes in bilateral breast cancer Comparison between synchronous and metachronous cancer Kim1, H; Lee, H; Choi, DH; Park, W; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Lee, SK; Cho, EY; Cho, SY
    View PubMed
  • BREAST CANCER RES TR 2020 10.1007/s10549-020-05874-1 Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer Kim1, JY; Jung, HH; Sohn, I; Woo, SY; Cho, H; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • DIAGN PATHOL 2020 10.1186/s13000-020-00995-z Accuracy and efficiency of an artificial intelligence tool when counting breast mitoses Pantanowitz1, L; Hartman, D; Qi, Y; Cho, EY; Suh, B; Paeng, K; Dhir, R; Michelow, P; Hazelhurst, S; Song, SY; Cho, SY
    View PubMed
  • ANTICANCER RES 2020 10.21873/anticanres.14271 Primary Peritoneal High-grade Serous Carcinoma Misinterpreted as Metastatic Breast Carcinoma: A Rare Encounter in Peritoneal Fluid Cytology Park1, S; Cho, EY; Oh, YL; Park, YH; Kim, HS
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-019-05192-1 miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway Lee1, J; Kim, HE; Song, YS; Cho, EY; Lee, A
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e17 Human Epidermal Growth Factor Receptor 2-positive Mucinous Carcinoma with Signet Ring Cell Differentiation, Which Showed Complete Response after Neoadjuvant Chemotherapy Jang1, Y; Cho, EY; Cho, SY
    View PubMed
  • J CELL MOL MED 2019 10.1111/jcmm.14194 Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non- small cell lung cancer cells Lee1, BB; Kim, Y; Kim, D; Cho, EY; Han, J; Kim, HK; Shim, YM; Kim, DH
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0212309 Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment Kwon1, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-4981-x A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients Hwang1, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY
    View PubMed
  • ANTICANCER RES 2019 10.21873/anticanres.13121 Clinicopathological and Molecular Characteristics of Mammary Adenoid Cystic Carcinoma With Adipocytic Differentiation With Emphasis on the Identification of a Novel BRAF Mutation Bae1, GE; Yoon, N; Cho, EY; Kim, HS; Cho, SY
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e48 PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis Seo1, Y; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Cho, SY; Cho, EY
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4858-z Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort Kim1, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • EXP MOL PATHOL 2018 10.1016/j.yexmp.2018.03.006 Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers Chin1, SF; Santonja, A; Grzelak, M; Ahn, S; Sammut, SJ; Clifford, H; Rueda, OM; Pugh, M; Goldgraben, MA; Bardwell, HA; Cho, EY; Provenzano, E; Rojo, F; Alba, E; Caldas, C
    View PubMed
  • Ultrasound Q 2017 10.1097/RUQ.0000000000000307 Lymphoma Involving Skin and Subcutaneous Fat of the Breast: Two Cases Kwon1, M; Ko, EY; Han, BK; Ko, YH; Cho, EY; Cho, SY; Kim, SY
    View PubMed
  • J BREAST CANC 2017 10.4048/jbc.2017.20.3.286 NanoString nCounter (R) Approach in Breast Cancer: A Comparative Analysis with Quantitative Real-Time Polymerase Chain Reaction, In Situ Hybridization, and Immunohistochemistry Hyeon1, J; Cho, SY; Hong, ME; Kang, SY; Doe, I; Im, YH; Cho, EY
    View PubMed
  • ASIA-PAC J CLIN ONCO 2017 10.1111/ajco.12652 Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy Kim1, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY
    View PubMed
  • INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10(2):1738-1746 Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) in pretherapeutic breast cancer core biopsies: Anti-tumoral effect of immune cells associated with neoadjuvant chemotherapy Yoon N1, Han KM, Cho SY, Kim SW, Lee JE, Nam SJ, Cho EY
    View PubMed
  • Genet Med. 2016 Dec;18(12):1250-1257. doi: 10.1038/gim.2016.39. Epub 2016 Apr 28. Comparative analysis of BRCA1 and BRCA2 variants of uncertain significance in patients with breast cancer: a multifactorial probability-based model versus ACMG standards and guidelines for interpreting sequence variants Park KS11, Cho EY2, Nam SJ3, Ki CS4, Kim JW4.
    View PubMed
  • Breast Cancer Res Treat. 2016 Dec;160(3):475-489. doi: 10.1007/s10549-016-4008-4. Epub 2016 Oct 11. Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems Choi M11, Park YH2, Ahn JS2, Im YH2, Nam SJ3, Cho SY4, Cho EY5.
    View PubMed
  • J Thorac Oncol. 2016 Dec;11(12):2193-2201. doi: 10.1016/j.jtho.2016.07.021. Epub 2016 Aug 4. Overexpression of beta-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA-IIA Squamous Cell Lung Cancer Irrespective of Adjuvant Chemotherapy Kim Y11, Jin D1, Lee BB1, Cho EY2, Han J2, Shim YM3, Kim HK3, Kim DH4.
    View PubMed
  • Cancer Res Treat. 2016 Oct;48(4):1338-1350. Epub 2016 Feb 18. Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer Kim JY11, Park K2, Jung HH3, Lee E2, Cho EY4, Lee KH5, Bae SY6, Lee SK6, Kim SW6, Lee JE6, Nam SJ6, Ahn JS1, Im YH1,3, Park YH1,3.
    View PubMed
  • J Breast Cancer. 2016 Sep;19(3):330-333. Epub 2016 Sep 23. Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review Seong M11, Ko EY1, Han BK1, Cho SY2, Cho EY2, Lee SK3, Lee JE3.
    View PubMed
  • Clin Breast Cancer. 2016 Jun;16(3):e15-21. doi: 10.1016/j.clbc.2015.11.008. Epub 2015 Dec 11. Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
    View PubMed
  • Sci Rep. 2016 Jun 24;6:28623. doi: 10.1038/srep28623. Gene Expression Profiling of Breast Cancer Brain Metastasis Lee JY11, Park K2, Lee E2, Ahn T2, Jung HH3, Lim SH1, Hong M4, Do IG4, Cho EY4, Kim DH5, Kim JY1, Ahn JS1, Im YH1,2, Park YH1,3.
    View PubMed
  • Genes Chromosomes Cancer. 2016 Jun;55(6):495-504. doi: 10.1002/gcc.22351. Epub 2016 Mar 3. Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade Yoon N11, Bae GE2, Kang SY1, Choi MS1, Hwang HW1, Kim SW3, Lee JE3, Nam SJ3, Gong G4, Lee HJ4, Bae YK5, Lee A6, Cho EY1.
    View PubMed
  • Acta Radiol. 2016 May;57(5):521-8. doi: 10.1177/0284185115590287. Epub 2015 Jun 12. Shear-wave elastography in invasive ductal carcinoma: correlation between quantitative maximum elasticity value and detailed pathological findings Cho EY11, Ko ES2, Han BK3, Kim RB4, Cho S1, Choi JS3, Hahn SY3.
    View PubMed
  • Int J Exp Pathol. 2016 Apr;97(2):170-7. doi: 10.1111/iep.12187. Epub 2016 Jun 9. Expression of FOXM1 and related proteins in breast cancer molecular subtypes Lee JJ11, Lee HJ2, Son BH3, Kim SB4, Ahn JH4, Ahn SD5, Cho EY6, Gong G2.
    View PubMed
  • Medicine (Baltimore). 2016 Jan;95(3):e2453. doi: 10.1097/MD.0000000000002453. Assessment of Invasive Breast Cancer Heterogeneity Using Whole-Tumor Magnetic Resonance Imaging Texture Analysis Correlations With Detailed Pathological Findings Ko ES11, Kim JH, Lim Y, Han BK, Cho EY, Nam SJ.
    View PubMed
  • PLoS One. 2015 Dec 2;10(12):e0144046. doi: 10.1371/journal.pone.0144046. eCollection 2015. Initial Experience with a Wireless Ultrasound-Guided Vacuum-Assisted Breast Biopsy Device Choi ER11, Han BK1, Ko ES1, Ko EY1, Choi JS1, Cho EY2, Nam SJ3.
    View PubMed
  • Clin Breast Cancer. 2015 Dec;15(6):512-8. doi: 10.1016/j.clbc.2015.06.004. Epub 2015 Jun 18. Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
    View PubMed
  • Clin Breast Cancer. 2015 Oct;15(5):353-61.e1-2. doi: 10.1016/j.clbc.2015.01.008. Epub 2015 Feb 7. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06) Yu JI11, Choi DH2, Huh SJ1, Cho EY3, Kim K4, Chie EK4, Ha SW4, Park IA5, Ahn SJ6, Lee JS7, Shin KH8, Kwon Y8, Kim YB9, Suh CO9, Koo JS10, Kim JH11, Jeong BG12, Kim IA13, Lee JH14, Park W1.
    View PubMed
  • Int J Cancer. 2015 Apr 15;136(8):1976-84. doi: 10.1002/ijc.29233. Epub 2014 Dec 24. A seven-gene signature can predict distant recurrence in patients with triple- negative breast cancers who receive adjuvant chemotherapy following surgery Park YH11, Jung HH, Do IG, Cho EY, Sohn I, Jung SH, Kil WH, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH.
    View PubMed
  • Radiology. 2015 Apr;275(1):235-44. doi: 10.1148/radiol.14141129. Epub 2014 Dec 11. Volume-based Metabolic Tumor Response to Neoadjuvant Chemotherapy Is Associated with an Increased Risk of Recurrence in Breast Cancer Hyun SH11, Ahn HK, Park YH, Im YH, Kil WH, Lee JE, Nam SJ, Cho EY, Choi JY.
    View PubMed
  • Clin Epigenetics. 2015 Mar 19;7(1):32. doi: 10.1186/s13148-015-0066-4. eCollection 2015. RAR beta 2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung Kim Y11, Jin D1, Lee BB1, Cho EY2, Han J2, Shim YM3, Kim DH4.
    View PubMed
  • Hum Pathol. 2014 Dec;45(12):2480-7. doi: 10.1016/j.humpath.2014.08.015. Epub 2014 Sep 7. Invasive Paget disease of the breast: 20 years of experience at a single institution Lee HW11, Kim TE1, Cho SY1, Kim SW2, Kil WH2, Lee JE2, Nam SJ2, Cho EY3.
    View PubMed
  • APMIS. 2014 Sep;122(9):755-60. doi: 10.1111/apm.12215. Epub 2013 Dec 20. Analysis of HER2 status in breast carcinoma by fully automated HER2 fluorescence in situ hybridization (FISH): comparison of two immunohistochemical tests and manual FISH Yoon N11, Do IG, Cho EY.
    View PubMed
  • Tumour Biol. 2014 Jul;35(7):7079-84. doi: 10.1007/s13277-014-1952-7. Epub 2014 Apr 24. Aberrant DNA methylation of integrin alpha 4 in human breast cancer Do SI11, Ko E, Kang SY, Lee JE, Nam SJ, Cho EY, Kim DH.
    View PubMed
  • Oncology. 2014;86(5-6):279-88. doi: 10.1159/000362281. Epub 2014 Jun 4. Validation and Comparison of CS-IHC4 Scores with a Nomogram to Predict Recurrence in Hormone Receptor-Positive Breast Cancers Park YH11, Im SA, Cho EY, Ahn JH, Woo SY, Kim S, Keam B, Lee JE, Han W, Nam SJ, Park IA, Noh DY, Yang JH, Ahn JS, Im YH.
    View PubMed
  • J Breast Cancer. 2014 Jun;17(2):113-20. doi: 10.4048/jbc.2014.17.2.113. Epub 2014 Jun 27. Positive Expression of Insulin-Like Growth Factor-1 Receptor Is Associated with a Positive Hormone Receptor Status and a Favorable Prognosis in Breast Cancer Shin SJ11, Gong G1, Lee HJ1, Kang J2, Bae YK3, Lee A4, Cho EY5, Lee JS6, Suh KS7, Lee DW8, Jung WH9.
    View PubMed
  • Radiology. 2014 Apr;271(1):30-7. doi: 10.1148/radiol.13131073. Epub 2013 Nov 21. Apparent Diffusion Coefficient in Estrogen Receptor-Positive Invasive Ductal Breast Carcinoma: Correlations with Tumor-Stroma Ratio Ko ES11, Han BK, Kim RB, Cho EY, Ahn S, Nam SJ, Ko EY, Shin JH, Hahn SY.
    View PubMed
  • J Breast Cancer. 2014 Mar;17(1):83-7. doi: 10.4048/jbc.2014.17.1.83. Epub 2014 Mar 28. Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ Lee JH11, Kim SY2, Lee JE1, Cho EY3, Choi YL3, Choi JY4, Han SW2, Kim SW1, Kil WH1, Nam SJ1.
    View PubMed
  • Korean J Radiol. 2014 Jan-Feb;15(1):20-8. doi: 10.3348/kjr.2014.15.1.20. Epub 2014 Jan 8. Breast Metastases from Extramammary Malignancies: Typical and Atypical Ultrasound Features Mun SH11, Ko EY2, Han BK2, Shin JH2, Kim SJ3, Cho EY4.
    View PubMed
  • Mod Pathol. 2013 May;26(5):677-84. doi: 10.1038/modpathol.2012.205. Epub 2012 Dec 14. Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas Cho EY11, Park K, Do I, Cho J, Kim J, Lee J, Kim S, Kim KM, Sohn TS, Kang WK, Kim S.
    View PubMed
  • Korean J Pathol. 2013 Apr;47(2):172-6. doi: 10.4132/KoreanJPathol.2013.47.2.172. Epub 2013 Apr 24. Congenital Peribronchial Myofibroblastic Tumor: A Case Study and Literature Review Kim Y11, Park HY, Cho J, Han J, Cho EY.
    View PubMed
  • Clin Cancer Res. 2013 Mar 1;19(5):1204-12. doi: 10.1158/1078-0432.CCR-12-2848. Epub 2013 Jan 14. Association of RASSF1A and p63 with Poor Recurrence-Free Survival in Node-Negative Stage I-II Non-Small Cell Lung Cancer Ko E11, Lee BB, Kim Y, Lee EJ, Cho EY, Han J, Shim YM, Park J, Kim DH.
    View PubMed
  • Ann Surg Oncol. 2013 Mar;20(3):1005-12. doi: 10.1245/s10434-012-2727-2. Epub 2012 Nov 1. Synergistic Effect of Bcl-2 and Cyclin A2 on Adverse Recurrence-Free Survival in Stage I Non-small Cell Lung Cancer Ko E11, Kim Y, Cho EY, Han J, Shim YM, Park J, Kim DH.
    View PubMed
  • Tumour Biol. 2013 Feb;34(1):445-53. doi: 10.1007/s13277-012-0569-y. Epub 2012 Nov 14. Expression of TWIST1, Snail, Slug, and NF-kappa B and methylation of the TWIST1 promoter in mammary phyllodes tumor Do SI11, Kim JY, Kang SY, Lee JJ, Lee JE, Nam SJ, Cho EY.
    View PubMed
  • Acta Oncol. 2013 Jan;52(1):73-81. doi: 10.3109/0284186X.2012.731520. Epub 2012 Oct 17. Prognostic impact of FOXP3 expression in triple-negative breast cancer Lee S11, Cho EY, Park YH, Ahn JS, Im YH.
    View PubMed
  • Korean J Pathol. 2012 Dec;46(6):554-61. doi: 10.4132/KoreanJPathol.2012.46.6.554. Epub 2012 Dec 26. Methylation and Immunoexpression of p16(INK4a) Tumor Suppressor Gene in Primary Breast Cancer Tissue and Their Quantitative p16(INK4a) Hypermethylation in Plasma by Real-Time PCR Lee JJ11, Ko E, Cho J, Park HY, Lee JE, Nam SJ, Kim DH, Cho EY.
    View PubMed
  • Am J Surg Pathol. 2012 Dec;36(12):1817-25. doi: 10.1097/PAS.0b013e318267b012. Hormone Receptor Expression in Invasive Breast Cancer Among Korean Women and Comparison of 3 Antiestrogen Receptor Antibodies A Multi-institutional Retrospective Study Using Tissue Microarrays Bae YK11, Gong G, Kang J, Lee A, Cho EY, Lee JS, Suh KS, Lee DW.
    View PubMed
  • J Breast Cancer. 2012 Dec;15(4):381-7. doi: 10.4048/jbc.2012.15.4.381. Epub 2012 Dec 31. HER2 Status by Standardized Immunohistochemistry and Silver-Enhanced In Situ Hybridization in Korean Breast Cancer Bae YK11, Gong G, Kang J, Lee A, Cho EY, Lee JS, Suh KS, Lee DW, Jung WH; Breast Pathology Study Group of Korean Society of Pathologists.
    View PubMed
  • Tumour Biol. 2012 Oct;33(5):1573-80. doi: 10.1007/s13277-012-0411-6. Epub 2012 May 13. The prognostic significance of tumor-associated stroma in invasive breast carcinoma Ahn S11, Cho J, Sung J, Lee JE, Nam SJ, Kim KM, Cho EY.
    View PubMed
  • Lung Cancer. 2012 Aug;77(2):401-6. doi: 10.1016/j.lungcan.2012.03.027. Epub 2012 Apr 24. Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer Ko E11, Kim Y, Park SE, Cho EY, Han J, Shim YM, Park J, Kim DH.
    View PubMed
  • Invest Radiol. 2012 Jun;47(6):368-75. doi: 10.1097/RLI.0b013e31824baff3. Hepatic Fat Quantification A Prospective Comparison of Magnetic Resonance Spectroscopy and Analysis Methods for Chemical-Shift Gradient Echo Magnetic Resonance Imaging With Histologic Assessment as the Reference Standard Kang BK11, Yu ES, Lee SS, Lee Y, Kim N, Sirlin CB, Cho EY, Yeom SK, Byun JH, Park SH, Lee MG.
    View PubMed
  • Pathology. 2012 Apr;44(3):216-20. doi: 10.1097/PAT.0b013e3283513e8b. Comparison of four immunohistochemical tests and FISH for measuring Her2 expression in gastric carcinomas Cho EY11, Srivastava A, Park K, Kim J, Lee MH, Do I, Lee J, Kim KM, Sohn TS, Kang WK, Kim S.
    View PubMed
  • Cancer?Chemother Pharmacol.?2011 Sep;68(3):753-61. doi: 10.1007/s00280-010-1548-x. Epub 2010 Dec 18. Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC) Cho EY11,?Chang MH,?Choi YL,?Lee JE,?Nam SJ,?Yang JH,?Park YH,?Ahn JS,?Im YH.
    View PubMed
  • Breast Cancer Res. 2010;12(6):R100. doi: 10.1186/bcr2783. Epub 2010 Nov 23. Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer Ko E11, Park SE, Cho EY, Kim Y, Hwang JA, Lee YS, Nam SJ, Bang S, Park J, Kim DH.
    View PubMed
  • Comparative Study of Metaplastic Breast Carcinoma and Triple-Negative Breast Carcinoma Using Histologic and Immunohistochemical Analyses
  • J Surg Oncol. 2010 Sep 1;102(3):225-9. doi: 10.1002/jso.21607. The Prediction of Lymph Node Metastasis in Ductal Carcinoma In Situ With Microinvasion by Assessing Lymphangiogenesis Lee SK11, Cho EY, Kim WW, Kim SH, Hur SM, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.
    View PubMed
  • Cancer Res. 2010 Jul 15;70(14):5674-8. doi: 10.1158/0008-5472.CAN-08-2660. Epub 2010 Jun 15. PIK3CA Mutations in In situ and Invasive Breast Carcinomas Miron A11, Varadi M, Carrasco D, Li H, Luongo L, Kim HJ, Park SY, Cho EY, Lewis G, Kehoe S, Iglehart JD, Dillon D, Allred DC, Macconaill L, Gelman R, Polyak K.
    View PubMed
  • No items found. Intracystic Papillary Carcinoma in the Male Breast
  • J Surg Oncol. 2010 Feb 1;101(2):137-40. doi: 10.1002/jso.21453. Characteristics of Metastasis in the Breast From Extramammary Malignancies Lee SK11, Kim WW, Kim SH, Hur SM, Kim S, Choi JH, Cho EY, Han SY, Hahn BK, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.
    View PubMed
  • No items found. Increased Expression of Autophagy Protein Beclin1 and LC3 in High-grade Hepatocellular Carcinoma and Metastatic Carcinoma
  • J Korean Med Sci. 2008 Dec;23(6):1053-61. doi: 10.3346/jkms.2008.23.6.1053. Epub 2008 Dec 24. Comparison of Her-2, EGFR and Cyclin D1 in Primary Breast Cancer and Paired Metastatic Lymph Nodes: An Immunohistochemical and Chromogenic In Situ Hybridization Study Cho EY11, Han JJ, Choi YL, Kim KM, Oh YL.
    View PubMed
  • Int J Cancer. 2008 Nov 1;123(9):2073-9. doi: 10.1002/ijc.23598. CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha 4 is associated with recurrence of early stage esophageal squamous cell carcinoma Lee EJ11, Lee BB, Han J, Cho EY, Shim YM, Park J, Kim DH.
    View PubMed
  • J Korean Med Sci. 2008 Apr;23(2):185-92. doi: 10.3346/jkms.2008.23.2.185. The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: Incidence of disease entities by age groups Cho EY11, Kim KH, Kim WS, Yoo KH, Koo HH, Ko YH.
    View PubMed
  • Pathol Int. 2008 Jan;58(1):17-25. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: Immunohistochemistry and chromogenic in situ hybridization Cho EY11, Choi YL, Han JJ, Kim KM, Oh YL.
    View PubMed
  • AJNR Am J Neuroradiol. 2007 Aug;28(7):1242-8. Spinal epidural hemangiomas: Various types of MR imaging features with histopathologic correlation Lee JW11, Cho EY, Hong SH, Chung HW, Kim JH, Chang KH, Choi JY, Yeom JS, Kang HS.
    View PubMed
  • APMIS. 2007 Jun;115(6):713-8. AMACR is highly expressed in gastric adenomas and intestinal-type carcinomas Cho EY11, Kim KM, Park CK, Kim JJ, Sohn TS, Kim DW.
    View PubMed
  • Cytopathology. 2007 Feb;18(1):20-7. Fine needle aspiration cytology of solitary fibrous tumours of the pleura Cho EY11, Han JJ, Han J, Oh YL.
    View PubMed
  • J Korean Med Sci. 2006 Jun;21(3):425-9. Polycystin-1 expression in fetal, adult and autosomal dominant polycystic kidney Chae SW11, Cho EY, Park MS, Lee KB, Kim H, Kim U.
    View PubMed
  • Int J Gynecol Cancer. 2006 May-Jun;16(3):1000-6. Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms Cho EY11, Choi YL, Chae SW, Sohn JH, Ahn GH.
    View PubMed
  • Eur J Cancer. 2006 May;42(7):972-80. Epub 2006 Mar 27. Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma Lee EJ11, Lee BB, Kim JW, Shim YM, Hoseok I, Han J, Cho EY, Park J, Kim DH.
    View PubMed
  • Radiology. 2006 Apr;239(1):105-12. Epub 2006 Feb 16. Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment Park SH11, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, Ha HK, Lee MG, Hwang S, Lee SG, Yu ES, Cho EY.
    View PubMed
  • Pathol Int. 2006 Feb;56(2):62-70. Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms Cho EY11, Choi Y, Chae SW, Sohn JH, Ahn GH.
    View PubMed
  • Hum Pathol. 2002 Jul;33(7):732-40. Focal follicular features in tonsillar diffuse large B-cell lymphomas: Follicular lymphoma with diffuse areas or follicular colonization Ree HJ11, Kikuchi M, Lee SS, Ohshima K, Yang WI, Ko YH, Cho EY, Rhee JC.
    View PubMed
  • J Korean Med Sci. 2002 Feb;17(1):137-40. Trilateral retinoblastoma: A case report Cho EY11, Suh YL, Shin HJ.
    View PubMed
  • Appl Immunohistochem Mol Morphol. 2001 Sep;9(3):222-8. Immunoexpression of inhibin alpha-subunit in adrenal neoplasms Cho EY11, Ahn GH.
    View PubMed
  • Hum Pathol. 2001 Sep;32(9):954-62. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: Significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma Ree HJ11, Yang WI, Kim CW, Huh J, Lee SS, Cho EY, Ko YH, Charney D.
    View PubMed
  • Acta Cytol. 2001 May-Jun;45(3):353-9. Fine needle aspiration cytology of sclerosing adenosis of the breast Cho EY11, Oh YL.
    View PubMed

해당하는 결과가 없습니다.